These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 33712900

  • 1. Association between adropin and coronary artery lesions in children with Kawasaki disease.
    Yang M, Pei Q, Zhang J, Weng H, Jing F, Yi Q.
    Eur J Pediatr; 2021 Jul; 180(7):2253-2259. PubMed ID: 33712900
    [Abstract] [Full Text] [Related]

  • 2. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
    Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545
    [Abstract] [Full Text] [Related]

  • 3. Plasma proteomic profiling reveals that SERPINE1 is a potential biomarker associated with coronary artery lesions in Kawasaki disease.
    Wang N, Gao Y, Wang Y, Dai Y, Tang Y, Huang J, Sun L, Qian G, Ma J, Li X, Liu Y, Yang D, Huang X, Wang W, Li W, Zhuo W, Lv H, Liu Z.
    Int Immunopharmacol; 2024 Sep 30; 139():112698. PubMed ID: 39029232
    [Abstract] [Full Text] [Related]

  • 4. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
    Shuai S, Zhang H, Zhang R, Tang M, Luo E, Yang Y, Gao Y, Yue S, Liang H, Cai J.
    J Pediatr (Rio J); 2023 Sep 30; 99(4):406-412. PubMed ID: 36977496
    [Abstract] [Full Text] [Related]

  • 5. The Relationship between Retinol-Binding Protein 4 and Markers of Inflammation and Thrombogenesis in Children with Kawasaki Disease.
    Yang M, Weng H, Pei Q, Jing F, Yi Q.
    Mediators Inflamm; 2021 Sep 30; 2021():7029514. PubMed ID: 33505217
    [Abstract] [Full Text] [Related]

  • 6. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.
    Feng H, Chai H, Li D, Shi C, Xu Y, Liu Y.
    Altern Ther Health Med; 2024 Jan 30; 30(1):302-306. PubMed ID: 37820655
    [Abstract] [Full Text] [Related]

  • 7. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
    Huiling L, Yaping L, Xiufen H.
    Zhonghua Er Ke Za Zhi; 2015 Apr 30; 53(4):300-3. PubMed ID: 26182507
    [Abstract] [Full Text] [Related]

  • 8. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Clin Exp Med; 2022 Nov 30; 22(4):621-628. PubMed ID: 35039938
    [Abstract] [Full Text] [Related]

  • 9. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.
    Chen YL, Wang JL, Li WQ.
    Eur J Pediatr; 2014 Nov 30; 173(11):1467-71. PubMed ID: 24889335
    [Abstract] [Full Text] [Related]

  • 10. Elevated Levels of Platelet Activating Factor and Its Acetylhydrolase Indicate High Risk of Kawasaki Disease.
    Yi L, Zhang J, Zhong J, Zheng Y.
    J Interferon Cytokine Res; 2020 Mar 30; 40(3):159-167. PubMed ID: 31841639
    [Abstract] [Full Text] [Related]

  • 11. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
    Wu Y, Wang S, Zhou Y, Yang Y, Li S, Yin W, Ding Y.
    PLoS One; 2023 Mar 30; 18(10):e0292653. PubMed ID: 37824465
    [Abstract] [Full Text] [Related]

  • 12. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
    Zhang X, Ya-Wang Shao, Ya-Lan Zhang, Yi Liu.
    Heart Surg Forum; 2021 Jul 26; 24(4):E611-E618. PubMed ID: 34473042
    [Abstract] [Full Text] [Related]

  • 13. Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions.
    Rong X, Jia L, Hong L, Pan L, Xue X, Zhang C, Lu J, Jin Z, Qiu H, Wu R, Chu M.
    J Cardiovasc Transl Res; 2017 Feb 26; 10(1):1-8. PubMed ID: 27981487
    [Abstract] [Full Text] [Related]

  • 14. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
    Duan Y, Li H, Luo D, Jiang J, Liu B, Li G.
    Int Immunopharmacol; 2023 Sep 26; 122():110600. PubMed ID: 37423157
    [Abstract] [Full Text] [Related]

  • 15. The role of Annexin A3 in coronary arterial lesions in children with Kawasaki disease.
    Li M, Liu D, Jing F, Liu R, Yi Q.
    Front Pediatr; 2023 Sep 26; 11():1111788. PubMed ID: 36865686
    [Abstract] [Full Text] [Related]

  • 16. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
    Peng Q, Deng Y, Yang X, Leng X, Yang Y, Liu H.
    Eur J Pediatr; 2016 May 26; 175(5):705-13. PubMed ID: 26833052
    [Abstract] [Full Text] [Related]

  • 17. The Systemic Immune-Inflammation Index (SII) and coronary artery lesions in Kawasaki disease.
    Huang T, Peng Q, Zhang Y, Zhu Z, Fan X.
    Clin Exp Med; 2024 Jan 17; 24(1):4. PubMed ID: 38231301
    [Abstract] [Full Text] [Related]

  • 18. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
    Zhang XY, He T, Ling JY, Hu XF, Wen Y, Wei J, Lu HL.
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul 17; 20(7):543-548. PubMed ID: 30022755
    [Abstract] [Full Text] [Related]

  • 19. The expression and significance of serum caveolin-1 in patients with Kawasaki disease.
    Zhu F, Huang J, Wang X, Li P, Yan Y, Zheng Y, He Y, Wu T, Ren Y, Wu R.
    Chin J Physiol; 2020 Jul 17; 63(2):90-94. PubMed ID: 32341235
    [Abstract] [Full Text] [Related]

  • 20. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J, Liu P, Hu W, Xu Y, Deng J.
    Clin Rheumatol; 2021 Oct 17; 40(10):4191-4197. PubMed ID: 34059986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.